Literature DB >> 26934199

Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome.

Laura Hencken1, Long To1, Nancy Ly2, Jeffrey A Morgan3.   

Abstract

Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26934199     DOI: 10.1111/jocs.12705

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

Review 1.  Serotonin syndrome in the perioperative period.

Authors:  A Bartakke; C Corredor; A van Rensburg
Journal:  BJA Educ       Date:  2019-12-04

Review 2.  From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.

Authors:  Donovan Tucker; Yujiao Lu; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

3.  Methylene blue may have a role in the treatment of COVID-19.

Authors:  Seyyed Mohammad Ghahestani; Elaheh Shahab; Sara Karimi; Mohammad Hamidi Madani
Journal:  Med Hypotheses       Date:  2020-08-06       Impact factor: 1.538

4.  Metoclopramide-induced Serotonin Syndrome.

Authors:  Sreenath Meegada; Rajiv Prakash Heda; Sanjaya Satapathy; Rajanshu Verma
Journal:  Cureus       Date:  2019-12-12

5.  Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.

Authors:  Othmar Kofler; Maximilian Simbeck; Roland Tomasi; Ludwig Christian Hinske; Laura Valentina Klotz; Florian Uhle; Frank Born; Maximilian Pichlmaier; Christian Hagl; Markus Alexander Weigand; Bernhard Zwißler; Vera von Dossow
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.